Nuclear pore complex protein Nup153
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 722–761 | Fragment:zf-RanBP domain | ZN ZINC ION × 1 | SOLUTION NMR NMR measurement conditions:pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient NMR sample composition:1.21 mM 13C, 15N-labeled protein; 20mM d-Tris-HCl(pH7.0); 100mM NaCl; 1mM d-DTT; 0.02%NaN3; 50uM ZnCl2+1mM IDA; 90% H2O, 10% D2O | 90% H2O/10% D2O | Resolution not provided |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 2EBQ | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 2EBR Solution structure of the fourth zf-RanBP domain from human Nuclear pore complex protein Nup153 Deposited 2007-02-09 | Different construct Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
851–890(40 aa)
Fragment:zf-RanBP domain
|
Not recorded | ZN ZINC ION × 1 |
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1.16 mM 13C, 15N-labeled protein; 20mM d-Tris-HCl(pH7.0); 100mM NaCl; 1mM d-DTT; 0.02%NaN3; 50uM ZnCl2+1mM IDA; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2EBV Solution structure of the third zf-RanBP domain from human Nuclear pore complex protein Nup153 Deposited 2007-02-09 | Different construct Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
773–822(50 aa)
Fragment:zf-RanBP domain
|
Not recorded | ZN ZINC ION × 1 |
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1.07mM 13C, 15N-labeled protein; 20mM d-Tris-HCl(pH7.0); 100mM NaCl; 1mM d-DTT; 0.02%NaN3; 50uM ZnCl2+1mM IDA, 90%H2O, 10%D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2GQE Molecular characterization of the Ran binding zinc finger domain Deposited 2006-04-20 | Different construct Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
722–750(29 aa)
Fragment:second zinc finger, residues 722-750
|
Not recorded | ZN ZINC ION × 1 |
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 70mM, 20mM Tris, 50mM NaCl;Pressure AMBIENT
NMR sample composition
1.3 mM hZnF2 U-15N, 13C, 20mM D-Tris, pH 7.0, 50mM NaCl, 1mM D-BME, 10 micromolr ZnCl2, 90%H2O, 10%D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 4U0C Hexameric HIV-1 CA in complex with Nup153 peptide, P6 crystal form Deposited 2014-07-11 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: Dodecameric |
Chain B
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 9.5;290 K;30% v/v PEG 400, 0.1 M CHES
|
Resolution 1.77 Å R-free 0.211 |
| 4U0D Hexameric HIV-1 CA in complex with Nup153 peptide, P212121 crystal form Deposited 2014-07-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 9 PDB declaration: Nonameric |
Chain M
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
Chain O
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
Chain P
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
|
Not recorded | CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;290 K;10% w/v PEG 8K, 0.1M imidazole
|
Resolution 3.00 Å R-free 0.267 |
| 4U0D Hexameric HIV-1 CA in complex with Nup153 peptide, P212121 crystal form Deposited 2014-07-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 9 PDB declaration: Nonameric |
Chain N
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
Chain Q
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
Chain R
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;290 K;10% w/v PEG 8K, 0.1M imidazole
|
Resolution 3.00 Å R-free 0.267 |
| 5TSV HIV-1 CA hexamer with NUP153 peptide - R3 crystal form Deposited 2016-10-31 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 9 PDB declaration: nonameric |
Chain D
1365–1387(23 aa)
|
Not recorded | FLU 2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;0.1 M Tris, pH 8.2
12% PEG 8000
2% Tacsimate
|
Resolution 2.50 Å R-free 0.251 |
| 5TSX HIV-1 CA hexamer with NUP153 peptide - P1 crystal form Deposited 2016-10-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 9 PDB declaration: nonameric |
Chain M
1365–1387(23 aa)
Chain P
1365–1387(23 aa)
Chain R
1365–1387(23 aa)
|
Not recorded | FLU 2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;0.1 M Tris, pH 9
12% PEG 8000
|
Resolution 1.90 Å R-free 0.228 |
| 5TSX HIV-1 CA hexamer with NUP153 peptide - P1 crystal form Deposited 2016-10-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 9 PDB declaration: nonameric |
Chain N
1365–1387(23 aa)
Chain O
1365–1387(23 aa)
Chain T
1365–1387(23 aa)
|
Not recorded | FLU 2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;0.1 M Tris, pH 9
12% PEG 8000
|
Resolution 1.90 Å R-free 0.228 |
| 6AYA Structure of the native full-length HIV-1 capsid protein in complex with Nup153 peptide Deposited 2017-09-07 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain B
1407–1423(17 aa)
|
Not recorded | IOD IODIDE ION × 42 CL CHLORIDE ION × 12 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;PEG3350, NaI, MIB, Glycerol
|
Resolution 2.40 Å R-free 0.274 |
| 8CKY HIV-1 mature capsid hexamer from CA-IP6 CLPs, bound to Nup153 peptide Deposited 2023-02-16 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain B
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.60 Å |
| 8CL0 HIV-1 mature capsid hexamer next to pentamer (type I) from CA-IP6 CLPs bound to Nup153 peptide. Deposited 2023-02-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain G
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
Chain H
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
Chain I
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
Chain J
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
Chain K
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
Chain L
1407–1423(17 aa)
Fragment:UNP residues 1407-1423
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.12 Å |
| 9CNU HIV-2 CA hexamer bound with Nup153 peptide; assembled with liposome templating Deposited 2024-07-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain B
1411–1425(15 aa)
Chain B
1464–1475(12 aa)
|
Mutation:Delta(1-1410) and Delta(1426-1463) Mutation:Delta(1-1410) and Delta(1426-1463) | IHP INOSITOL HEXAKISPHOSPHATE × 12 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7;The mixed buffer of storage buffer for the protein and lipid components with IP6 supplemented.
cryo-EM vitrification conditions
Cryogen ETHANE;Grids were dual-side blotted with blot force 0 for 5.5 sec before plunge freezing in liquid ethane.
|
Resolution 2.99 Å |
| 9CNU HIV-2 CA hexamer bound with Nup153 peptide; assembled with liposome templating Deposited 2024-07-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1411–1425(15 aa)
Chain B
1464–1475(12 aa)
|
Mutation:Delta(1-1410) and Delta(1426-1463) Mutation:Delta(1-1410) and Delta(1426-1463) | IHP INOSITOL HEXAKISPHOSPHATE × 2 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7;The mixed buffer of storage buffer for the protein and lipid components with IP6 supplemented.
cryo-EM vitrification conditions
Cryogen ETHANE;Grids were dual-side blotted with blot force 0 for 5.5 sec before plunge freezing in liquid ethane.
|
Resolution 2.99 Å |
11 other PDB entries and 14 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | NU153_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 8–47; UniProt 722–761 |